From: Influence of an alkalizing supplement on markers of endurance performance using a double-blind placebo-controlled design
Group
W60 for the
Familiarization
Trial (W)
W60 for
Pre-Testing
Post-Testing
Placebo
(n = 12)
187 ± 24
186 ± 23
188 ± 22
Treatment
190 ± 24
†198 ± 25